The rising cost of vitamin D testing in Australia: time to establish guidelines for testing

  title={The rising cost of vitamin D testing in Australia: time to establish guidelines for testing},
  author={Kellie L Bilinski and Steven C. Boyages},
  journal={Medical Journal of Australia},
TO THE EDITOR: A rising awareness of the prevalence of 25hydroxyvitamin D (25OHD) deficiency over the past decade is likely to have led to a surge in the number of individuals who undergo 25OHD testing.1 United States data indicate that testing for 25OHD has increased by 80%–90% annually,2 yet there are no reports that investigate the cost of 25OHD testing in Australia. We analysed the Medicare Benefits Schedule (MBS) to determine the economic impact of vitamin D testing in Australia from 1… 

Topics from this paper

Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data
The marked variation in the frequency of testing for vitamin D deficiency indicates that large sums of potentially unnecessary funds are being expended and further research is required to determine the drivers and cost benefit of such expenditure.
Vitamin D testing: Impact of changes to testing guidelines on detection of patients at risk of vitamin D deficiency
The results showed an initial fall in requests took place after the introduction of changes, but request numbers had returned to pre-change levels by November 2016 and the failure of the intervention to improve the detection of vitamin D deficiency was significant.
Testing for vitamin D and other trends in the clinical management of osteoporosis
The management of osteoporosis in Australia has been characterised by a movement away from single to combination formularies, and its consumption has undergone a 20-fold increase since 2006.
Potentially inappropriate testing for vitamin D deficiency: a cross-sectional study in Switzerland
Despite recommendations for routine vitamin D supplementation, vitamin D testing of low risk individuals is common and increasing in Switzerland, and the total laboratory cost to mandatory insurance was about 90 million Swiss francs in 2018.
Insignificant Medium-Term Vitamin D Status Change after 25-Hydroxyvitamin D Testing in a Large Managed Care Population
Objectives To examine the clinical utility of 25-hydroxyvitamin D (25(OH)D) testing in achieving medium-term vitamin D (VD) sufficiency in a managed care population. Methods Retrospective study of a
The Vitamin D paradox: Bone density testing in females aged 45 to 74 did not increase over a ten-year period despite a marked increase in testing for vitamin D
It is demonstrated that improved detection of vitamin D deficiency is not being translated into better detection in at-risk women of the consequences ofitamin D deficiency on target organs such as bone, demonstrating a massive missed opportunity for improved bone health and reduced fracture risk.
Patterns of Clinical Care Subsequent to Nonindicated Vitamin D Testing in Primary Care
Evidence of a health service cascade following nonindicated vitamin D testing exists and opportunities for improved consistency and quality of care related to vitamin D were observed in the health system.
Vitamin D Supplementation in Australia: Implications for the Development of Supplementation Guidelines
There is an urgent need for a better understanding of supplementation use and for the development of supplementation, whereby over A$94 million supplements containing vitamin D in Australia were sold during the year 2010.
Recruitment and results of a pilot trial of vitamin D supplementation in the general population of Australia.
The D-Health pilot has shown that a large trial of vitamin D supplementation for the reduction of cancer incidence and overall mortality in Australia is feasible and that a dose of 2000 IU/d will be needed to ensure that aLarge proportion of the population reaches the target serum 25(OH)D level.
Vitamin D prescribing in children in UK primary care practices: a population-based cohort study
There has been a marked and sustained increase in vitamin D supplementation prescribing in children in UK primary care, and the data suggests that national guidelines onitamin D supplementation for children are not consistently followed by GPs.


Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D?
Assays for serum 25-hydroxy vitamin D (25-OH-D), the accepted marker for vitamin D nutritional status, are not standardized, raising questions about the adequacy of the methods used to make these measurements.
Seasonal reduction in vitamin D level persists into spring in NSW Australia: implications for monitoring and replacement therapy
Seasonal variation in 25‐hydroxyvitamin D [25OHD] status and its relationship to gender, age, socioeconomic and geographic determinants in Australians has not been described in large biomedical